Perioperative Fluid Management According to the Preoperative and Perioperative Glucose Level
1 other identifier
interventional
250
0 countries
N/A
Brief Summary
Background:Hyperglycemia and hypoglycemia both cause detrimental side effects for pediatric patients. Prolonged fasting time, age dependent physiological diffences and individual differences of patients make complicated the perioperative fluid therapy. Isotonic electrolyte solutions without glucose or with lower glucose concentrations recommended for intraoperative period in pediatric patients. Objective: The aim of this prospective study is to evaluate the different glucose concentrations(without dextrose, 1 % dextrose+LR, 2 % dextrose+LR) in perioperative infusion solutions according to preoperative blood glucose level to maintain normoglycemia in pediatric patients. Method: The consecutive 250 eligible pediatric patients aged between 6 months- 12 years with ASA risk score of I-II undergoing surgery lasting less than four hours were enrolled the study in six months period. Patient demographics, procedure, preoperative fasting time, preoperative and postoperative glucose levels were documented. Lactate ringer (LR) solution with % 2 glucose was infused to the patients with preoperative blood glucose level lower than 60 mg/dL, LR solution with % 1 glucose was used for the patients with preoperative blood glucose level between 60-90 mg/dL, LR solution without glucose was used for the patients with preoperative blood glucose level higher than 90 mg/dL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 20, 2017
CompletedFirst Posted
Study publicly available on registry
May 20, 2019
CompletedMay 20, 2019
May 1, 2019
3 months
August 20, 2017
May 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
glucose level
blood glucose level measurement with finger stick monitoring
perioperative period
Secondary Outcomes (1)
hyperglysemia or hypoglysemia ratio
perioperative
Study Arms (3)
non glucose infusion group
ACTIVE COMPARATORDrug: LR infusion LR solution without glucose; the patients with preoperative blood glucose level higher than 90 mg/dL.
Drug:1% Dextrose infusion group
ACTIVE COMPARATORDrug:LR+ 1% Dextrose infusion LR solution with % 1 glucose: the patients with preoperative blood glucose level between 60-90 mg/dL,
2% Dextrose infusion group
ACTIVE COMPARATORDrug:LR+ 2 % Dextrose infusion Lactate ringer (LR) solution with % 2 glucose; the patients with preoperative blood glucose level lower than 60 mg/dL,
Interventions
Drug: infusing dextrose containing or non glucose fluid according to blood glucose level
Eligibility Criteria
You may not qualify if:
- Diabetes mellitus
- Parenteral nutrition or enteral nutrition
- Patient with metabolic disorders,
- ASA III-IV patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
August 20, 2017
First Posted
May 20, 2019
Study Start
January 1, 2015
Primary Completion
April 1, 2015
Study Completion
July 1, 2016
Last Updated
May 20, 2019
Record last verified: 2019-05